US lab equipment and services business Thermo Fisher Scientific has opened a new clinical and commercial ultra-cold facility in Bleiswijk, Netherlands.
The new site specialises in ambient to cryogenic storage, clinical and commercial packaging, labelling and distribution, and clinical qualified person release services. Thermo Fisher has said it will help to meet increasing demand from cell and gene therapy clinical trials in Europe and to accelerate the development of advanced therapies.
Go deeper with GlobalData
Spread across 5,000sqm, the facility accommodates space for clinical and commercial packaging services for cell and gene therapy products, end-to-end biorepository storage solutions and associated supply chain services. It is Current Good Manufacturing Practice (cGMP)-certified.
The site uses 15% solar power and operates gas-free while providing sustainable heating and cooling as part of its global goal of achieving net-zero emissions by 2050.
Molly Flick, vice president and general manager of bio-services and speciality logistics at Thermo Fisher, said: “The opening of this cutting-edge facility supporting the development of cell and gene therapies and other biologics, coupled with our proven track record in managing valuable materials, places us in an unmatched position to help our global clients develop innovative therapies.”
Earlier this year, Thermo Fisher expanded its operations in Indonesia with the opening of its first official office in Jakarta. In February, it opened a new sterile drug facility in Singapore.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataHeadquartered in the US state of Massachusetts, Thermo Fisher Scientific has around 122,000 employees globally.
